Biocon Limited — Important, 20-06-2025: General Updates

Biocon has announced a board meeting on to discuss the financial results for the quarter and half-year. The company completed a qualified institutions placement, issuing 136.36 million equity shares at ₹330 each, raising ₹4,500 Cr. Post-issuance, paid-up equity capital increased to ₹668.48 Cr. Major allotments included ICICI Prudential Value Discovery Fund (6.5%), SBI Contra Fund (6.7%), and HDFC Life Insurance (7.7%). This capital raise strengthens Biocon’s balance sheet to support growth and expansion initiatives.